Inhibition of miR-142-3p promotes intestinal epithelial proliferation and barrier function after ischemia/reperfusion

Yuhang Wang1,2, Zirui Jia1,2, Mingcan Zheng1,2

  • 1Department of Gastroenterology Surgery, the Central Hospital of Dalian University of Technology (Dalian Municipal Central Hospital), No. 826 of Southwest Road Shahekou District, Dalian, 116033, People's Republic of China.

Insights

MicroRNA-142 (miR-142) increases after intestinal ischemia/reperfusion (I/R) injury, impairing barrier function. Inhibiting miR-142 enhances intestinal epithelial proliferation and barrier function, improving survival rates.

Area of Science:

  • Gastroenterology
  • Molecular Biology
  • Regenerative Medicine

Background:

  • Intestinal ischemia/reperfusion (I/R) injury severely damages intestinal barrier function (BF), leading to high mortality.
  • MicroRNAs (miRNAs) are implicated in regulating intestinal mucosal BF and epithelial proliferation post-I/R.
  • Understanding the specific roles of miRNAs in I/R injury is crucial for developing therapeutic strategies.

Purpose of the Study:

  • To investigate the role and regulatory mechanism of miR-142-3p (miR-142) in intestinal epithelial proliferation and BF following I/R injury.
  • To determine if miR-142 directly targets key regulatory molecules involved in intestinal repair.
  • To assess the therapeutic potential of modulating miR-142 in I/R injury models.

Main Methods:

  • Analysis of miR-142 expression, proliferation, and BF in clinical ischemic intestinal tissues.
  • Establishment of in vivo (mouse I/R) and in vitro (IEC-6 cell hypoxia/reoxygenation) models.
  • Manipulation of miR-142 expression levels to evaluate its impact on intestinal epithelial cells and survival rates.
  • Bioinformatics analysis and luciferase assays to identify direct miR-142 targets.

Main Results:

  • miR-142 expression was significantly elevated in clinical and experimental I/R-injured intestinal tissues.
  • Increased miR-142 inversely correlated with intestinal epithelial proliferation and BF.
  • Inhibition of miR-142 markedly enhanced intestinal epithelial proliferation and BF post-I/R injury.
  • miR-142 directly targets Forkhead box M1 (FoxM1), a key regulator of cell proliferation.
  • Blocking miR-142 improved the survival rate of mice subjected to I/R injury.

Conclusions:

  • miR-142 plays a detrimental role in intestinal epithelial proliferation and BF after I/R injury.
  • Inhibition of miR-142 represents a promising therapeutic strategy for I/R injury by promoting intestinal repair via FoxM1.
  • Targeting miR-142 offers a novel approach to improve outcomes in patients suffering from intestinal I/R injury.

Related Concept Videos

Renewal of Intestinal Stem Cells01:23

Renewal of Intestinal Stem Cells

The intestinal epithelial lining rapidly renews every 4 to 5 days. The renewal is facilitated by intestinal stem cells (ISCs) located at the base of the crypt– a gland located at the bottom of each villus. ISCs divide asymmetrically to form new stem cells and progenitor daughter cells. The daughter cells are called transit-amplifying (TA) cells which move upwards along the crypt and either differentiate into absorptive cells– the enterocytes or secretory cells– including the...
2.5K
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.1K
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.2K